S0078 HCPCS Level II code: Injection, fosphenytoin sodium, 750 mg
S0078 is the HCPCS code for “Injection, fosphenytoin sodium, 750 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S0078Injection, fosphenytoin sodium, 750 mg
Short description: Injection, fosphenytoin sodi
HCPCS · United States
Notes for S0078
As CMS prints them, with any note S0078 takes from the headings above it.
Note
- CMS processing note 0088: "S" CODES ARE UNIQUE TEMPORARY CODES ESTABLISHED BY BCBSA AND HIAA FOR PRIVATE PAYOR USE. THEY ARE NOT VALID NOR PAYABLE BY MEDICARE.
Medicare details
The indicators CMS publishes with S0078 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Undefined codes
- Added
- Jan 1, 2000
Where S0078 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S0078Injection, fosphenytoin sodium, 750 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S0078 mean?
S0078 is the HCPCS code for “Injection, fosphenytoin sodium, 750 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S0078?
CMS lists S0078’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S0078
All S codesS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole and trimethoprim, 10 mlS0040Injection, ticarcillin disodium and clavulanate potassium, 3.1 gramsS0073Injection, aztreonam, 500 mgS0074Injection, cefotetan disodium, 500 mgS0077Injection, clindamycin phosphate, 300 mgS0080Injection, pentamidine isethionate, 300 mgS0081Injection, piperacillin sodium, 500 mgS0088Imatinib, 100 mgS0090Sildenafil citrate, 25 mgS0091Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)S0092Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)